| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.79T | 2.80T | 2.73T | 2.79T | 2.44T | 2.23T |
| Gross Profit | 274.07B | 298.40B | 311.11B | 312.25B | 370.74B | 224.74B |
| EBITDA | 148.69B | 185.44B | 204.49B | 217.55B | 289.26B | 154.85B |
| Net Income | 30.95B | 57.67B | 82.06B | 67.94B | 138.89B | 85.91B |
Balance Sheet | ||||||
| Total Assets | 2.11T | 2.16T | 2.21T | 2.12T | 1.94T | 1.71T |
| Cash, Cash Equivalents and Short-Term Investments | 147.45B | 217.68B | 117.30B | 168.91B | 80.33B | 52.97B |
| Total Debt | 668.87B | 697.81B | 698.89B | 777.82B | 681.84B | 609.84B |
| Total Liabilities | 1.42T | 1.45T | 1.49T | 1.46T | 1.35T | 1.26T |
| Stockholders Equity | 562.95B | 584.78B | 601.16B | 527.89B | 456.20B | 324.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 43.36B | 96.42B | -45.08B | 58.89B | 89.60B |
| Operating Cash Flow | 0.00 | 137.21B | 178.01B | 8.23B | 108.46B | 167.53B |
| Investing Cash Flow | 0.00 | -145.46B | -28.33B | -79.06B | -67.61B | -84.66B |
| Financing Cash Flow | 0.00 | -69.34B | -108.69B | 78.91B | -42.04B | -80.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥138.71B | 17.49 | ― | 2.57% | 7.46% | 153.98% | |
73 Outperform | ¥743.42B | 15.20 | ― | 3.93% | 2.57% | -4.79% | |
68 Neutral | ¥2.05T | 21.95 | 2.23% | 3.07% | -7.68% | -73.03% | |
68 Neutral | ¥81.43B | 32.15 | ― | 1.37% | -5.02% | 186.97% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | ¥230.16B | 12.70 | ― | 3.45% | -4.87% | 26.27% | |
56 Neutral | ¥3.95T | 11.54 | -0.15% | 2.74% | -14.13% | 33.18% |